99 related articles for article (PubMed ID: 17955427)
1. Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men.
Kim JJ
J Infect Dis; 2007 Oct; 196(8):1117-9. PubMed ID: 17955427
[No Abstract] [Full Text] [Related]
2. Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?
Günther OP; Ogilvie G; Naus M; Young E; Patrick DM; Dobson S; Duval B; Noël PA; Marra F; Miller D; Brunham RC; Pourbohloul B
J Infect Dis; 2008 Jun; 197(12):1653-61. PubMed ID: 18513154
[TBL] [Abstract][Full Text] [Related]
3. Towards global prevention of human papillomavirus-induced cancer.
Roden RB; Gravitt P; Wu TC
Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245
[No Abstract] [Full Text] [Related]
4. Human papillomavirus vaccines: WHO position paper.
Who
Biologicals; 2009 Oct; 37(5):338-44. PubMed ID: 19525124
[No Abstract] [Full Text] [Related]
5. The use of human papillomavirus seroepidemiology to inform vaccine policy.
Schiffman M; Safaeian M; Wentzensen N
Sex Transm Dis; 2009 Nov; 36(11):675-9. PubMed ID: 19773679
[No Abstract] [Full Text] [Related]
6. StatBite: Prevalence of HPV in a cohort of U.S. men.
J Natl Cancer Inst; 2009 Feb; 101(4):223. PubMed ID: 19211451
[No Abstract] [Full Text] [Related]
7. HPV vaccine catch up schedule - an opportunity for chlamydia screening.
Grotowski M; May J
Aust Fam Physician; 2008 Jul; 37(7):529-30. PubMed ID: 18592070
[TBL] [Abstract][Full Text] [Related]
8. Merck hopes to extend gardasil vaccine to men.
Chitale R
J Natl Cancer Inst; 2009 Feb; 101(4):222-3. PubMed ID: 19211446
[No Abstract] [Full Text] [Related]
9. Bandicoots, bonobos, and boys: papillomavirus and vaccination strategies.
Grose C
Pediatrics; 2009 Apr; 123(4):1244-5. PubMed ID: 19336384
[No Abstract] [Full Text] [Related]
10. Introduction. The human papillomavirus VLP vaccines.
Stanley M
Gynecol Oncol; 2010 Jun; 118(1 Suppl):S1. PubMed ID: 20494218
[No Abstract] [Full Text] [Related]
11. One in four California adolescent girls have had human papillomavirus vaccination.
Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
[No Abstract] [Full Text] [Related]
12. Human papilloma virus vaccine: a new frontier or political controversy?
Forman SF; Woods ER
Curr Opin Pediatr; 2007 Aug; 19(4):387-8. PubMed ID: 17630600
[No Abstract] [Full Text] [Related]
13. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
14. Primary and secondary prevention of cervical cancer--opportunities and challenges.
Markowitz LE; Unger ER; Saraiya M
J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
[No Abstract] [Full Text] [Related]
15. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccination: the policy debate over the prevention of cervical cancer--a commentary.
Hoops KE; Twiggs LB
J Low Genit Tract Dis; 2008 Jul; 12(3):181-4. PubMed ID: 18596458
[TBL] [Abstract][Full Text] [Related]
17. Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
Villa LL
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S17-25. PubMed ID: 18162241
[TBL] [Abstract][Full Text] [Related]
18. Oral sexual behaviors and the prevalence of oral human papillomavirus infection.
Kreimer AR
J Infect Dis; 2009 May; 199(9):1253-4. PubMed ID: 19320591
[No Abstract] [Full Text] [Related]
19. Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
Gauthier A; Martín-Escudero V; Moore L; Ferko N; de Sanjosé S; Pérez-Escolano I; Catalá-López F; Ferrer E; Bosch FX
Eur J Public Health; 2008 Dec; 18(6):674-80. PubMed ID: 18641420
[TBL] [Abstract][Full Text] [Related]
20. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
Giuliano AR; Salmon D
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
